Coronavirus: The Latest

Auteur(s): The Telegraph
  • Résumé

  • The latest Coronavirus news from The Telegraph’s leading journalists, with analysis of the impact on health, business and travel in the UK and beyond.

    Hosted on Acast. See acast.com/privacy for more information.

    © Copyright 2021. All rights reserved.
    Voir plus Voir moins
activate_Holiday_promo_in_buybox_DT_T2
Épisodes
  • Has hospitality been unfairly targeted?
    Nov 24 2020

    It employs nearly one in ten UK workers, but it’s the industry set to suffer the most when England's new tier system comes into force. CEO of UKHospitality, Kate Nicholls tells Theodora Louloudis why limited evidence of infection in pubs and restaurants means the sector has been wrongly singled out, with ‘devastating’ consequences.

    Read more on Christmas rules: https://bit.ly/361oNwP |

    Read more on travel quarantine changes: https://bit.ly/371PVLG |

    'Dosing error in trials led to Oxford vaccine's 90 per cent efficacy by accident': https://bit.ly/39bzCOU |

    For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

    Email: coronaviruspodcast@telegraph.co.uk |

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    12 min
  • How promising is Remdesivir?
    Nov 19 2020

    Over a year since the first recorded case of Covid-19 in humans, only one antiviral drug is approved for its treatment. The Telegraph’s Global Health Security team speak to Dr Michael Elliot, Vice President of Medical Affairs at Gilead Sciences, the company that manufactures Remdesivir. They discuss how useful it is, whether big pharma is solely driven by profit and the prognosis for severe coronavirus sufferers in the second wave.

    Read more on the Oxford vaccine: https://bit.ly/2UVfPet |

    Read more on Brexit talks: https://bit.ly/36V8f8Y |

    Read more on the new quarantine-free list: https://bit.ly/3lMs88H |

    For 30 days' free access to The Telegraph: https://www.telegraph.co.uk/audio |

    Email: coronaviruspodcast@telegraph.co.uk |

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    15 min
  • The five challenges facing Joe Biden
    Nov 13 2020

    After the US recorded its highest daily rise in new cases and hospitalisations, Deputy Editor of The Telegraph’s Global Health Security Team, Anne Gulland joins Theodora Louloudis to discuss the five mammoth challenges the President Elect will be seeking to overcome in his fight against Covid-19. Top of the list? Tackling misinformation.

    Track cases in your area: https://bit.ly/2Yohewr |

    Read more about the MS drug trial: https://bit.ly/3kB3nuM |

    For 30 days' free access to The Telegraph: www.telegraph.co.uk/audio |

    Email: coronaviruspodcast@telegraph.co.uk |

    See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    15 min

Ce que les auditeurs disent de Coronavirus: The Latest

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.